2,4,8-Trimethyl-7-nonen-2-OL
Common Name: |
2,4,8-Trimethyl-7-nonen-2-OL |
IUPAC Name: |
2,4,8-trimethylnon-7-en-2-ol |
Molecular Formula: |
C13H16O4 |
SMILES: |
CC(CCC=C(C)C)CC(C)(C)O |
Inchi: |
1S/C12H24O/c1-10(2)7-6-8-11(3)9-12(4,5)13/h7,11,13H,6,8-9H2,1-5H3 |
Inchi Key: |
QRDZETOZNQTTCN-UHFFFAOYSA-N |
Cas No: |
437770-28-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
236.26 |
Mass (g/mol) |
184.183 |
Molar Refractivity |
63.42 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
6 |
Rings |
|
TPSA |
52.60 |
Hetero Atoms |
1 |
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
242.00 to 243.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.005 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.38 |
LogP |
3.53 |
iLOGP |
2.86 |
XLOGP3 |
2.29 |
WLOGP |
2.30 |
MLOGP |
2.39 |
ESOL Log S |
-2.61 |
ESOL Solubility (mg/ml) |
0.576 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.03 |
Ali Solubility (mg/ml) |
0.22 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.40 |
Silicos-IT Solubility (mg/ml) |
0.09 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.12 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.051 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.829 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |